NEW YORK, NY / ACCESSWIRE / March 26, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

World Wrestling Entertainment, Inc. (NYSE:WWE)
Class Period: February 7, 2019 to February 5, 2020
Lead Plaintiff Deadline: May 5, 2020

The complaint alleges that during the class period World Wrestling Entertainment, Inc. made materially false and/or misleading statements and/or failed to disclose that: Defendants perpetrated a fraudulent scheme which: (i) deceived the investing public regarding WWE's business and prospects; (ii) artificially inflated the price of WWE Class A common stock; (iii) permitted certain senior executives of WWE to sell more than $282 million worth of their personally held shares at fraud inflated prices; and (iv) caused the public to purchase WWE Class A common stock at artificially inflated prices.

Learn about your recoverable losses in WWE: http://www.kleinstocklaw.com/pslra-1/world-wrestling-entertainment-inc-loss-submission-form?id=5817&from=1

MGP Ingredients, Inc. (NASDAQ:MGPI)
Class Period: February 27, 2019 to February 25, 2020
Lead Plaintiff Deadline: April 28, 2020

The MGPI lawsuit alleges that throughout the class period, MGP Ingredients, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) MGP had not completed any significant sales of its four-year-old aged whiskey inventory; (b) the Company had been unable to sell its aged whiskey at the price premium represented to investors; (c) a glut of aged whiskey inventory and shifts in consumer behavior had lowered the value of the Company's aged whiskey inventory and materially impaired its ability to negotiate significant sales on favorable contract terms; and (d) in light of the foregoing, the Company's FY19 financial forecast lacked a reasonable basis and was materially misleading.

Learn about your recoverable losses in MGPI: http://www.kleinstocklaw.com/pslra-1/mgp-ingredients-inc-loss-submission-form?id=5817&from=1

Cronos Group Inc. (NASDAQ:CRON)
Class Period: May 9, 2019 to March 2, 2020
Lead Plaintiff Deadline: May 11, 2020

The complaint alleges Cronos Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (ii) the foregoing would foreseeably necessitate reviews that would delay the Company's ability to timely file its periodic reports; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in CRON: http://www.kleinstocklaw.com/pslra-1/cronos-group-inc-loss-submission-form-2?id=5817&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 582688

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Luckin Coffee Inc. (NASDAQ:LK)

Investors Affected : November 13, 2019 – January 31, 2020

A class action has commenced on behalf of certain shareholders in Luckin Coffee Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) certain of Luckin's financial performance metrics, including per-store per-day sales, net selling price per item, advertising expenses, and revenue contribution from "other products" were inflated; (ii) Luckin's financial results thus overstated the Company's financial health and were consequently unreliable; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/luckin-coffee-inc-loss-submission-form/?id=5816&from=1

HP Inc. (NYSE:HPQ)

Investors Affected : February 23, 2017 – October 3, 2019

A class action has commenced on behalf of certain shareholders in HP Inc. According to the filed complaint, defendants knew that HP's "four-box" model for measuring its supplies business was severely deficient and not a strong predictor of supplies demand and outcomes because HP lacked telemetry data from its commercial printers and had to use unreliable and stagnant market share data to develop assumptions for the four-box model. The complaint further alleges that defendants knew the lack of telemetry data for commercial printing was a critical shortcoming of the four-box model because HP possessed telemetry data on its personal printing side and knew it was a necessary element for an accurate understanding of the supplies channel. As a result, the supplies inventory in the Company's channel exceeded demand by at least $100 million and HP's supplies revenue growth was grossly inflated.

Shareholders may find more information at https://securitiesclasslaw.com/securities/hp-inc-loss-submission-form/?id=5816&from=1

Tilray, Inc. (NASDAQ:TLRY)

Investors Affected : January 15, 2019 – March 2, 2020

A class action has commenced on behalf of certain shareholders in Tilray, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the purported advantages of the marketing and revenue sharing agreement with Authentic Brands Group (the "ABG Agreement")were significantly overstated; (ii) the under performance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/tilray-inc-loss-submission-form/?id=5816&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 582686

VANCOUVER, BC / ACCESSWIRE / March 26, 2020 / Maple Leaf Short Duration 2020 Flow-Through Limited Partnership (the "Partnership") is pleased to announce that it has completed its second and final closing on March 26, 2020 with aggregate gross proceeds of $21,074,900.00.

Partnership Objectives & Benefits – National Class Units

The Partnership is designed to provide holders of National Class Units ("National Class Limited Partners") with an investment in a diversified portfolio of Flow-Through Shares of Resource Companies incurring Eligible Expenditures (as those terms are defined in the Prospectus) across Canada with a view to maximizing the tax benefits of an investment in National Class Units and achieving capital appreciation and/or income for National Class Limited Partners. National Class Limited Partners must be residents of Canada or liable to pay Canadian income tax.

Investors are expected to receive tax deductions for 2020 of approximately 100% of the amount invested based on and subject to certain conditions as set forth in the Prospectus.

Partnership Objectives & Benefits – Québec Class Units

The Partnership is designed to provide holders of Québec Class Units ("Québec Class Limited Partners") with an investment in a diversified portfolio of Flow-Through Shares of Resource Companies incurring Eligible Expenditures principally in the Province of Québec with a view to maximizing the tax benefits of an investment in Québec Class Units and achieving capital appreciation and/or income for Québec Class Limited Partners. Québec Class Units are most suitable for investors who reside in the Province Québec or are liable to pay income tax in Québec.

Investors are expected to receive tax deductions for 2020 of up to approximately 131% of the amount invested based on and subject to certain conditions as set forth in the Prospectus.

Liquidity Event

The investment portfolios of both the National and Québec Class Units will be actively managed in such a way as to preserve the ability to undertake a future liquidity event, such as a rollover into a mutual fund corporation.

The Syndicate

The syndicate of agents for the offering is being led by Scotia Capital Inc. and includes National Bank Financial Inc., CIBC World Markets Inc., BMO Nesbitt Burns Inc., Industrial Alliance Securities Inc., Stifel Nicolaus Canada Inc., Canaccord Genuity Corp., Desjardins Securities Inc., Echelon Wealth Partners Inc., Manulife Securities Incorporated, Raymond James Ltd. and Laurentian Bank Securities Inc.

A copy of the Prospectus can be obtained from any agent.

Offering Jurisdictions
Each of the Provinces and Territories of Canada.

FOR FURTHER INFORMATION, PLEASE CONTACT:
Hugh Cartwright, Chairman
MAPLE LEAF FLOW-THROUGH PROGRAMS
Tel: 1-866-688-5750
Email: info@mapleleaffunds.ca
Web: www.MapleLeafFunds.ca

SOURCE: Maple Leaf Short Duration 2020 Flow-Through Limited Partnership

ReleaseID: 582687

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Jeld-Wen Holding, Inc. (NYSE:JELD)
Class Period: January 26, 2017 to October 15, 2018
Lead Plaintiff Deadline: April 20, 2020

According to the complaint, Jeld-Wen Holding, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's products, including doors, did not compete against other manufacturers on price, contrary to Jeld-Wen's representations; (2) the market in which the Company sells its doors is not "highly competitive" as the Company claimed; (3) Jeld-Wen's strong margins and anticipated margin growth were not, as the Company claimed, attributed to changes they had made in Jeld-Wen's business operations and strategies; and (4) Jeld-Wen failed to disclose the Company's anti competitive conduct. Because of the foregoing, Defendants' statements about the Company's business, operations and prospects lacked a reasonable basis.

Learn about your recoverable losses in JELD: http://www.kleinstocklaw.com/pslra-1/jeld-wen-holding-inc-loss-submission-form?id=5815&from=1

Tupperware Brands Corporation (NYSE:TUP)
Class Period: January 30, 2019 to February 24, 2020
Lead Plaintiff Deadline: April 27, 2020

The complaint alleges that throughout the class period Tupperware Brands Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) Tupperware lacked effective internal controls; (2) as a result, Tupperware would need to investigate the accounting and liabilities of one of its brands, Fuller Mexico; (3) consequently, Tupperware would be unable to timely file its annual report on Form 10-K for its fiscal year 2019; (4) Tupperware did not properly account for its accounts payable and accrued liabilities at Fuller Mexico; (5) Tupperware provided overvalued earnings per share guidance; (6) Tupperware would need relief from its $650 million Credit Agreement; and (7) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in TUP: http://www.kleinstocklaw.com/pslra-1/tupperware-brands-corporation-loss-submission-form?id=5815&from=1

Becton Dickinson & Company (NYSE:BDX)
Class Period: November 5, 2019 to February 5, 2020
Lead Plaintiff Deadline: April 27, 2020

The BDX lawsuit alleges Becton Dickinson & Company made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) certain of Becton's Alaris infusion pumps experienced software errors and alarm prioritization issues; (2) as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to "make enhancements;" (3) the Company was reasonably likely to face regulatory delays in connection with the software remediation; (4) as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in BDX: http://www.kleinstocklaw.com/pslra-1/becton-dickinson-company-loss-submission-form?id=5815&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 582684

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

WBK Shareholders Click Here: https://www.zlk.com/pslra-1/westpac-banking-corporation-loss-form?prid=5814&wire=1
AAN Shareholders Click Here: https://www.zlk.com/pslra-1/aarons-inc-loss-form?prid=5814&wire=1
ALGN Shareholders Click Here: https://www.zlk.com/pslra-1/align-technology-inc-loss-form-2?prid=5814&wire=1

* ADDITIONAL INFORMATION BELOW *

Westpac Banking Corporation (NYSE:WBK)

WBK Lawsuit on behalf of: investors who purchased November 11, 2015 – November 19, 2019
Lead Plaintiff Deadline : March 30, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/westpac-banking-corporation-loss-form?prid=5814&wire=1

According to the filed complaint, during the class period, Westpac Banking Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre ("AUSTRAC"); (2) the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) the Westpac did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) the Company's Anti-Money Laundering and Counter-Terrorism Financing Policy Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Aarons, Inc. (NYSE:AAN)

AAN Lawsuit on behalf of: investors who purchased March 2, 2018 – February 19, 2020
Lead Plaintiff Deadline : April 28, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/aarons-inc-loss-form?prid=5814&wire=1

According to the filed complaint, during the class period, Aarons, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Aaron's had inadequate disclosure controls, procedures, and compliance measures; (ii) consequently, the operations of Aaron's Progressive Leasing ("Progressive") and Aaron's Business ("AB") segments were in violation of the Federal Trade Commission ("FTC") Act and/or relevant FTC regulations; (iii) consequently, Aaron's earnings from those segments were partially derived from unlawful business practices and were thus unsustainable; (iv) the full extent of Aaron's liability regarding the FTC's investigation into its Progressive and AB segments, Aaron's noncompliance with the FTC Act, and the likely negative consequences of all the foregoing on the Company's financial results; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Align Technology, Inc. (NASDAQ:ALGN)

ALGN Lawsuit on behalf of: investors who purchased April 24, 2019 – July 24, 2019
Lead Plaintiff Deadline : May 1, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/align-technology-inc-loss-form-2?prid=5814&wire=1

According to the filed complaint, during the class period, Align Technology, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) Align was then experiencing a significant decline in demand for its products in the important Chinese market; (b) Chinese consumer sentiment towards the Company was deteriorating; and (c) as a result of the foregoing, Defendants' positive statements about Align and its businesses were lacking in a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 582683

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Beyond Meat, Inc. (NASDAQ:BYND)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/beyond-meat-inc-loss-submission-form?prid=5813&wire=1
Lead Plaintiff Deadline: March 30, 2020
Class Period: May 2, 2019 to January 27, 2020

Allegations against BYND include that: (i) Beyond Meat's termination of its supply agreement with Don Lee constituted a breach of that agreement, thus exposing the Company to foreseeable legal liability and reputational harm; (ii) Beyond Meat and certain of its employees had doctored and omitted material information from a food safety consultant's report, which the Company represented as accurate to Don Lee; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/inovio-pharmaceuticals-inc-loss-submission-form?prid=5813&wire=1
Lead Plaintiff Deadline: May 12, 2020
Class Period: February 14, 2020 to March 9, 2020

According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

XP Inc. (NASDAQ:XP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/xp-inc-loss-submission-form?prid=5813&wire=1
Lead Plaintiff Deadline: May 20, 2020
Class Period: or otherwise acquired XP's securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with XP's December 2019 initial public offering.

Allegations against XP include that: (1) XP engaged in undisclosed related party transactions; (2) XP failed to disclose its common and large system failures and connected losses; (3) XP's aggressive IFA strategy was and is tenuous; (4) XP had material weaknesses; (5) XP fired its previous accounting firm due to that firm finding and disclosing material weaknesses; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 582682

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the Company") (NASDAQ:INO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Inovio securities between February 14, 2020 and March 9, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/ino.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statementsabout Inovio's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/ino or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Inovio you have until May 11, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 581988

PLANO, TX / ACCESSWIRE / March 26, 2020 / iDocsWeb, developer and marketer of a proprietary Telemedicine Platform today announced they are making the technology available for one month at no cost to any Skilled Nursing or Long-Term Care Facility and ALF across the United States.

The company's founder and CEO, Dr. Suresh Nellore MD and Infectious Disease Specialist, has taken this action considering the concerns over COVID-19, more commonly referred to as the Coronavirus. He explained "with this pandemic reaching epic proportions in the United States, it is paramount for institutions to minimize workers' and patients' exposure. The use of telemedicine as the name implies will reduce the number of in person contacts that can possibly lead to the spread of this deadly virus."

Specifically, with Nursing Home quarantines in effect nationwide the iDocsWeb Family application allows for virtual visits between family members or responsible parties with the facility resident.

Concerned physicians can avoid cross infection risks by using the iDocsWeb Provider applications to administer remote treatment to their Nursing Home patients.

iDocsWeb currently has its telemedicine platform functioning in Long Term Care, Skilled Nursing Facilities, ALF's and Doctors' offices throughout the United States.

About the virus: An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 172 other countries and territories, including the United States. As of March 25, there were a total of 66,048 cases diagnosed in the United States and 944 deaths. A state of emergency has been declared for the U.S. Our government and public health partners and individual states have implemented aggressive measures to slow and contain the transmission of COVID-19.

Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this virus and the outbreak, CDC will rapidly incorporate new knowledge into guidance for action.

About iDocsWeb: iDocsWeb is a telemedicine company founded in 2013 that serves residents in long-term and post-acute care facilities, throughout the United States, who are in need of healthcare advice for non-life-threatening illnesses or injuries. The iDocsWeb cloud-based and HIPAA compliant Telemedicine solution provides consultation with a doctor within minutes. It is striving to bring comfort to patients without the agony of long, tedious and costly visits to the hospital emergency department, while avoiding the potential exposure to various healthcare associated infections. iDocsWeb offers a specifically tailored telemedicine platform that allows RN's, Nurse Practitioner and Board-Certified Physicians to consult with its client facilities 24 hours a day, seven days a week.

For more information contact Al Forcella, Senior Vice President, at 727-492-4679, or aforcella@idocsweb.com, info@idocsweb.com

SOURCE: iDocsWeb LLC

ReleaseID: 582649

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Cronos Group Inc. (NASDAQ: CRON)
Class Period: May 9, 2019 – March 2, 2020
Deadline: May 11, 2020
For more info: www.bgandg.com/cron

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (2) the foregoing would foreseeably necessitate reviews that would delay the Company's ability to timely file its periodic reports; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

NMC Health Plc (OTCMKT: NMHLY)
Class Period: March 13, 2016 – March 10, 2020
Deadline: May 11, 2020
For more info: www.bgandg.com/nmhly

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked effective internal controls and risk management; (2) the Company engaged in undisclosed and extensive related party and de facto related party transactions; (3) NMC's debts were significantly understated and obfuscated; (4) NMC's cash-on-hand figures were overstated; (5) NMC's principal shareholders were not accurately reporting or accounting their interests or stakes in the Company; (6) NMC did not review or know their principal shareholders interests or stakes in the Company; (7) consequently, the Company was not enforcing its Relationship Agreement with the principal shareholders; and (8) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 581980

The growing trend of metrosexuality is primarily responsible for shaping the growth trajectory of the male colour cosmetics market. Changing consumer perception has a major role to play in the growth of the male colour cosmetics market.

DUBAI, UAE / ACCESSWIRE / March 26, 2020 / The global male colour cosmetics market will grow at a promising rate of 11% during the forecast period. According to the latest report from Future Market Insights (FMI), market players are adopting new strategies of marketing and advertising to reach a larger segment of consumers. Changing consumer perception regarding men's looks has been a major driving force in the male colour cosmetics market.

"Market players are leveraging innovations and to develop novel male colour cosmetics products. They are further strengthening their market presence in online platforms to generate greater revenue and attain more penetration amongst consumers," says the FMI report.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11158

Male Colour Cosmetics Market: Key Findings

Facial products will grow at 12.3% CAGR during the forecast period, significantly boosting the growth of the male colour cosmetics market.
The individual segment will contribute major revenue share in the market; commercial segment to gain rapid traction.
E-commerce distribution channels will experience high popularity owing to the convenience of doorstep delivery.
East Asia and Europe will hold more than 40% of the market on the back of the surge in aspirations regarding men's fashion.

Male Colour Cosmetics Market: Key Growth Drivers

Emerging trends of metrosexuality and lumber sexuality act as a growth lever in the male colour cosmetics market.
The surge in promotional campaigns encouraging men's fashion is positively influencing the adoption rate of male colour cosmetics.
An increase in the adoption of face products across the commercial sector is bolstering the market growth.
Growing e-commerce penetration has a major influence on the overall sale of male colour cosmetics products in the market.

Male Colour Cosmetics Market: Key Impediments

The growing trend of clean beauty is challenging the chemical-based male colour cosmetic products in the market, thereby restraining the market growth.

Explore the complete male colour cosmetics market report with 197 illustrative figures, 107 data tables, and the table of contents. Also find a detailed market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-11158

Male Colour Cosmetics Market: Competition Landscape

Market players are making huge investments in innovations to launch new products into the market. They are introducing organic products in the market to add value to their existing business. Established companies are adopting different marketing and promotional activities to enhance the sale of their products.

Explore Future Market Insights' detailed coverage on,

Pet Insurance Market: This research report offers a deep-dive into the insights on the market revenue dynamics, key growth strategies, and potentially profitable opportunities, associated with the pet insurance market.

Mini Refrigerator Market: This report provides detailed information on competitive landscape and essential details about major market participants in the automatic mini-refrigerator market.

Secondhand Apparel Market: This study encompasses details on primary and secondary research, employed to evaluate prominent industry players, size of the market, and major industry associations of the secondhand apparel market.

Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solutions to solve the complex strategy challenges that organizations face today.

About the Report

This report offers market analysis on regional and global levels and provides the emerging trends in the market influencing the male colour cosmetics market. The study gives actionable details on the male colour cosmetics market based on product type (Lip product, eye products, and face products), end-user (individual and commercial), nature (natural and synthetic) across 6 major regions (North America, Europe, Latin America, South Asia & Pacific, Middle East & Africa and East Asia).

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Market Report: https://www.futuremarketinsights.com/reports/male-colour-cosmetics-market
Press Release Source: https://www.futuremarketinsights.com/press-release/male-colour-cosmetics-marke

SOURCE: Future Market Insights

ReleaseID: 582681